Skip to results
Modify your search
NARROW
1-20 of 58
Authors: Quinn Ostrom
Sort by
Journal Article
EPID-23. HISTORY OF TYPE III IMMUNE HYPERSENSITIVITY IMPROVES SURVIVAL IN GLIOBLASTOMA
Corey Neff and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii142–viii143, https://doi.org/10.1093/neuonc/noae165.0559
Published: 11 November 2024
Journal Article
EPID-16. GENOMIC ANCESTRY-RELATED RISK RATIOS FOR GLIOBLASTOMA INCIDENCE AMONG GLOBAL POPULATIONS AND RACIAL/ETHNIC GROUPS WITHIN THE UNITED STATES
Christine Ballard and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii141, https://doi.org/10.1093/neuonc/noae165.0552
Published: 11 November 2024
Journal Article
IMMU-09. REVERSING SYSTEMIC T CELL DYSFUNCTION TO LICENSE IMMUNOTHERAPY IN INTRACRANIAL TUMORS
Lucas Wachsmuth and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii153, https://doi.org/10.1093/neuonc/noae165.0602
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Mary Jane Lim-Fat and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 13–32, https://doi.org/10.1093/neuonc/noae186
Published: 23 October 2024
Journal Article
IMMU-49. BETA-ADRENERGIC BLOCKADE LICENSES THE USE OF IMMUNOTHERAPY IN PRIMARY AND METASTATIC BRAIN TUMORS
Selena Lorrey and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v153, https://doi.org/10.1093/neuonc/noad179.0581
Published: 10 November 2023
Journal Article
EPID-18. THE GENOMIC ARCHITECTURE OF GLIOBLASTOMA PREDISPOSITION IS HIGHLY POLYGENIC IN PATIENTS WITH A POSITIVE FAMILY HISTORY OF GLIOMA
Kyle Walsh and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v119, https://doi.org/10.1093/neuonc/noad179.0450
Published: 10 November 2023
Journal Article
NCOG-19. SEX DIFFERENCES IN GLIOBLASTOMA TREATMENT AND ADVERSE EVENTS
Mantas Dmukauskas and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v217–v218, https://doi.org/10.1093/neuonc/noad179.0832
Published: 10 November 2023
Journal Article
EPID-02. HISTORY OF ALLERGY OR ATOPY DECREASES RISK OF BRAIN METASTASIS IN LUNG CANCER AND MELANOMA
Corey Neff and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v115, https://doi.org/10.1093/neuonc/noad179.0434
Published: 10 November 2023
Journal Article
EPID-28. YEARS OF LIFE LOST FOR BRAIN AND OTHER CENTRAL NERVOUS SYSTEM TUMORS IN THE UNITED STATES, 2018
Corey Neff and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v121, https://doi.org/10.1093/neuonc/noad179.0460
Published: 10 November 2023
Journal Article
EPID-11. THE IMPACT OF THE COVID-19 PANDEMIC ON TREATMENT PATTERNS IN GLIOBLASTOMA
Corey Neff and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v117, https://doi.org/10.1093/neuonc/noad179.0443
Published: 10 November 2023
Journal Article
EPID-24. CAPTURING EVOLVING DEFINITIONS OF 12 SELECT RARE CNS TUMORS: A TIMELY REPORT FROM CBTRUS AND NCI-CONNECT
Mackenzie Price and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v120–v121, https://doi.org/10.1093/neuonc/noad179.0456
Published: 10 November 2023
Journal Article
EPID-31. BRAIN TUMORS IN UNITED STATES MILITARY VETERANS
Kristin Waite and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v122, https://doi.org/10.1093/neuonc/noad179.0463
Published: 10 November 2023
Journal Article
EPID-20. MORTALITY TRENDS IN PRIMARY MALIGNANT BRAIN AND CENTRAL NERVOUS SYSTEM TUMORS VARY BY HISTOPATHOLOGY, AGE, RACE, AND SEX
Marisa Thierheimer and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii113–vii114, https://doi.org/10.1093/neuonc/noac209.430
Published: 14 November 2022
Journal Article
EPID-06. IMPROVEMENTS IN SURVIVAL FOR GLIOBLASTOMA IN THE POST-STUPP PROTOCOL ERA
Corey Neff and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii110, https://doi.org/10.1093/neuonc/noac209.416
Published: 14 November 2022
Journal Article
EPID-19. CHANGES IN SURVIVAL OVER TIME FOR ALL PRIMARY BRAIN AND OTHER CNS TUMORS IN THE UNITED STATES
Jacob Edelson and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii113, https://doi.org/10.1093/neuonc/noac209.429
Published: 14 November 2022
Journal Article
BIOM-23. MOLECULAR MARKER TESTING AND REPORTING COMPLETENESS FOR ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES
Corey Neff and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii9, https://doi.org/10.1093/neuonc/noac209.033
Published: 14 November 2022
Journal Article
EPID-11. NATIONAL EPIDEMIOLOGY AND SURVIVAL OF ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES BY IDH, 1P/19Q, MGMT, AND WHO CNS GRADE
Bryan Iorgulescu and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii111–vii112, https://doi.org/10.1093/neuonc/noac209.421
Published: 14 November 2022
Journal Article
EPID-05. A novel, clinically-relevant classification of pediatric CNS tumors for cancer registries using a clustering analysis
Daniel Moreira and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i47, https://doi.org/10.1093/neuonc/noac079.173
Published: 03 June 2022
Journal Article
A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act
Sheantel J Reihl and others
Neuro-Oncology, Volume 24, Issue 8, August 2022, Pages 1341–1349, https://doi.org/10.1093/neuonc/noac011
Published: 06 January 2022
Journal Article
EPID-06. ASSOCIATIONS BETWEEN GERMLINE GENETIC VARIANTS AND OVERALL SURVIVAL IN PATIENTS WITH GLIOMA
Kunal Potnis and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi86, https://doi.org/10.1093/neuonc/noab196.339
Published: 12 November 2021
Advertisement
Advertisement